1 documents found
Information × Registration Number 0120U103333, ( 0221U101265  0222U000782  ) R & D request Title Development of cardiomyogenic fibroblast reprogramming technology using CRISPR-Cas9 system as a potential method of improving heart function after heart attack Head Piven Oksana O., Кандидат біологічних наук Registration Date 10-07-2020 Organization Institute of Molecular Biology and Genetics of NAS of Ukraine popup.description1 The aim of our work is to study the capabilities of the CRISPR -Cas9 system and to develop a method for reprogramming fibroblasts into cardiomyocytes using a variant of the gene editing system - CRISPRa. The result of our work will be a new potential approach to restoring myocardial function after a heart attack. popup.nrat_date 2024-12-10 Close
search.res_rk
Development of cardiomyogenic fibroblast reprogramming technology using CRISPR-Cas9 system as a potential method of improving heart function after heart attack
Head: Piven Oksana O.. Development of cardiomyogenic fibroblast reprogramming technology using CRISPR-Cas9 system as a potential method of improving heart function after heart attack. Institute of Molecular Biology and Genetics of NAS of Ukraine. № 0120U103333
1 documents found

Updated: 2026-03-23


Роздрукувати цю сторінку